They are made by Novo Nordisk, and its market value “has risen by more than a third so far this year to about $419 billion, bigger than the country’s gross domestic product of about $406 billion,” according to The Wall Street Journal. “Because the pharmaceutical industry’s exports have grown so much, it’s creating a big influx of currency into the Danish economy,” Danske Bank director Jens Naervig Pedersen tells WSJ.